Works matching IS 00221899 AND DT 2022 AND VI 226 AND IP 8
Results: 25
Effectiveness of CoronaVac and BNT162b2 Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Infections in Hong Kong.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1382, doi. 10.1093/infdis/jiac360
- By:
- Publication type:
- Article
Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1396, doi. 10.1093/infdis/jiac358
- By:
- Publication type:
- Article
Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1418, doi. 10.1093/infdis/jiac356
- By:
- Publication type:
- Article
Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1412, doi. 10.1093/infdis/jiac333
- By:
- Publication type:
- Article
The IDOze Study: The Link Between Sleep Disruption and Tryptophan-Kynurenine Pathway Activation in Women With Human Immunodeficiency Virus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1407, doi. 10.1093/infdis/jiac261
- By:
- Publication type:
- Article
Factors Associated With Human IgG Antibody Response to Anopheles albimanus Salivary Gland Extract, Artibonite Department, Haiti, 2017.
- Published in:
- 2022
- By:
- Publication type:
- journal article
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1401, doi. 10.1093/infdis/jiac241
- By:
- Publication type:
- Article
HIV-Associated Alterations of the Biophysical Features of Maternal Antibodies Correlate With Their Reduced Transfer Across the Placenta.
- Published in:
- 2022
- By:
- Publication type:
- journal article
One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Specific Components Associated With the Endothelial Glycocalyx Are Lost From Brain Capillaries in Cerebral Malaria.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Individual, Household, and Community Drivers of Dengue Virus Infection Risk in Kamphaeng Phet Province, Thailand.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Preserved Mucosal-Associated Invariant T Cells in the Cervical Mucosa of HIV-Infected Women with Dominant Expression of the TRAV1-2-TRAJ20 T Cell Receptor α-Chain.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1385, doi. 10.1093/infdis/jiac161
- By:
- Publication type:
- Article
Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1481, doi. 10.1093/infdis/jiac159
- By:
- Publication type:
- Article
Omicron BA.1, BA.2 and COVID-19 Booster Vaccination.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1480, doi. 10.1093/infdis/jiac158
- By:
- Publication type:
- Article
Economics of Eradication: Counting on the Polio Experience.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Polio by the Numbers-A Global Perspective.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1304, doi. 10.1093/infdis/jiac113
- By:
- Publication type:
- Article
Hyperinflammatory Syndrome, Natural Killer Cell Function, and Genetic Polymorphisms in the Pathogenesis of Severe Dengue.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1372, doi. 10.1093/infdis/jiac092
- By:
- Publication type:
- Article
Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1357, doi. 10.1093/infdis/jiab142
- By:
- Publication type:
- Article